Larvol Delta - Recombinant-Human-Adenovirusp53-Therapy-for-the-Treatment-of-Oral-Leukoplakia-and-Oral-Squamous-Cell-Carcinoma-A-Systematic-Review

Gendicine (rAd-p53 Gene Therapy) - Benda Pharma

http://www.ncbi.nlm.nih.gov/pubmed/34062896

Jun 3, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next